ALNY
Alnylam Pharmaceuticals Inc
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
alnylam is developing an entirely new class of innovative medicines based on a breakthrough discovery in biology known as rna interference, or rnai. with rnai technology, we have the opportunity to treat disease and impact the lives of patients in a fundamentally new way by silencing disease-causing genes upstream of today's medicines.
Market Cap: 18.8 Billion
Primary Exchange: NASDAQ
Website: https://www.alnylam.com/
Shares Outstanding: 126 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 0.0
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Ethical Flags
Longest drawdown: 603 trading days
From: 2015-06-22 To: 2017-11-09
Lowest Point:
Alnylam to Report New Clinical Results for ONPATTRO® (patisiran) at Peripheral Nerve Society (PNS) Annual Meeting and the 5th Congress of the European Academy of Neurology (EAN)
via: Business Wire at 2019-06-13 04:00:00:000
Data from Ongoing Open-Label Extension Study Highlight Durable Halting or Reversal of Neuropathy Disease Progression Relative to Baseline and Consistent Safety Profile of ONPATTRO in Patients with hATTR Amyloidosis Alnylam to Share Data Evaluating Treatment w… read more...
BIIB Is For Buy-O-Gen
via: SeekingAlpha at 2019-06-12 06:30:36:000
Let's spell Biogen Buy-o-Gen. Indeed, BIIB seems increasingly appealing at current price. The biotech focuses on discovering, developing, and delivering therapies to people living with serious neurological, rare and autoimmune diseases. The Company markets various products for multiple sc… read more...
Alnylam Pharmaceuticals (ALNY) Investor Presentation - Slideshow
via: SeekingAlpha at 2019-06-10 07:37:51:000
The following slide deck was published by Alnylam Pharmaceuticals, Inc. in conjunction with this Read more … read more...
Alnylam Pharmaceuticals (ALNY) Investor Presentation - Slideshow
via: SeekingAlpha at 2019-06-10 07:37:51:000
The following slide deck was published by Alnylam Pharmaceuticals, Inc. in conjunction with this Read more … read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|